hepatitiscomics.blogspot.com
The Hepatitis Comics: Levity for the Liver: Saying Goodbye to The Hepatitis Comics
http://hepatitiscomics.blogspot.com/2013/12/saying-goodbye-to-hepatitis-comics.html
The Hepatitis Comics: Levity for the Liver. Bile humor and hepatainment to tickle the liver. Saturday, December 7, 2013. Saying Goodbye to The Hepatitis Comics. It is with mixed emotions that I have decided to retire The. I created this blog in October 2009 after learning about cancer bloggers who poked humor at aspects of their disease. For more than four years I’ve been laughing at my hepatic self, cracking jaundiced jokes and trying to soften the impact of living with liver disease. Lucinda Porter, RN.
hepcawareness.com
Links to great Sites
http://www.hepcawareness.com/Links_to_great_Sites_4BVR.html
This is a good place to go for information about Cirrhosis. Sadly it is an outcome for some people with Hep C. The information is put together in an easy to read format. Http:/ www.hepatitis.va.gov/patient/complications/cirrhosis-single-page.asp. His is a website for people who are looking for information and understanding about HCV, and US Military Vets. Please support their fight for justice. Links to great Sites. Links to great Sites. CATC is the Canadian Treatment Action Council. The mission of Organ...
nonfictionauthorsassociation.com
2013 Nonfiction Writers Conference Recordings | Nonfiction Authors Association
http://nonfictionauthorsassociation.com/nonfiction-writers-conference-recordings-2013
Book Marketing – Online. Interviews – Authors, Members, Experts. Nonfiction Book Awards FAQ. Nonfiction Book Awards Categories. Book Reviewers Apply Here. Directory of Local Chapters. Become a Chapter Leader. List of Internet Radio Shows and Podcasts. Lists of Blogs that Accept Guest Blog Posts. Nonfiction Writers Conference Recordings. Media Lists and Press Release Distribution. BOOK: Nonfiction Book Marketing Plan. Best Books for Nonfiction Authors. 2013 Nonfiction Writers Conference Recordings. Includ...
hepcawareness.com
Great Article
http://www.hepcawareness.com/Great_Article.html
Links to great Sites. Hepatitis C: Get Tested. By Lucinda K. Porter, RN. The Centers for Disease Control and Prevention (CDC) estimate the number of people in the U.S. with chronic hepatitis C virus infection (HCV) is 3.2 million. [i]. Other research places the figure closer to 5 million or more. [ii]. The bottom line is this—there are a lot of people in the U.S. with HCV. Worldwide, there are 150-170 million people with this virus. [iv]. Although Baby Boomers make-up nearly ¼ of the population, the...
hepatitiscnewdrugs.blogspot.com
HCV New Drug Research : Boehringer Ingelheim halts further development of deleobuvir-containing hepatitis C regimens
https://hepatitiscnewdrugs.blogspot.com/2014/01/boehringer-ingelheim-halts-further.html
HCV New Drug Research. Boehringer Ingelheim halts further development of deleobuvir-containing hepatitis C regimens. Wednesday, January 29, 2014. Posted by HCV New Drugs. File Under BI 207127. Boehringer Ingelheim halts further development of deleobuvir-containing hepatitis C regimens. January 17, 2014 Reprinted from company statement by Boehringer Ingelheim. Faldaprevir, Boehringer Ingelheim's investigational HCV protease inhibitor, has shown promising results in combination with pegylated interferon an...
hepatitiscnewdrugs.blogspot.com
HCV New Drug Research : FDA Approves AbbVie Combo Hepatitis C Treatment
https://hepatitiscnewdrugs.blogspot.com/2014/12/fda-approves-abbvie-combo-hepatitis-c.html
HCV New Drug Research. FDA Approves AbbVie Combo Hepatitis C Treatment. Friday, December 19, 2014. Posted by HCV New Drugs. File Under HCV next. FDA approves Viekira Pak to treat hepatitis C. December 19, 2014. The US. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
hepatitiscnewdrugs.blogspot.com
HCV New Drug Research : Vertex ends hepatitis C investment as sales fall
https://hepatitiscnewdrugs.blogspot.com/2014/05/vertex-ends-hepatitis-c-investment-as.html
HCV New Drug Research. Vertex ends hepatitis C investment as sales fall. Thursday, May 1, 2014. Posted by HCV New Drugs. File Under ALS-2200 (VX-135). Vertex ends hepatitis C investment as sales fall. NEW YORK (AP) — Vertex Pharmaceuticals, which reported more than $1 billion in sales of its hepatitis C drug Incivek in 2012, said Thursday it won't invest any more money on research and development of new treatments for the disease. Twitter Follow me on Twitter! Rss Subscribe to my Rss feeds! Also known as...
hepatitiscomics.blogspot.com
The Hepatitis Comics: Levity for the Liver: December 2013
http://hepatitiscomics.blogspot.com/2013_12_01_archive.html
The Hepatitis Comics: Levity for the Liver. Bile humor and hepatainment to tickle the liver. Saturday, December 7, 2013. Saying Goodbye to The Hepatitis Comics. It is with mixed emotions that I have decided to retire The. I created this blog in October 2009 after learning about cancer bloggers who poked humor at aspects of their disease. For more than four years I’ve been laughing at my hepatic self, cracking jaundiced jokes and trying to soften the impact of living with liver disease. Links to this post.
hepatitiscnewdrugs.blogspot.com
HCV New Drug Research : Coffee reduces the risk of hepatic fibrosis in Hep C
https://hepatitiscnewdrugs.blogspot.com/2015/08/coffee-reduces-risk-of-hepatic-fibrosis.html
HCV New Drug Research. Coffee reduces the risk of hepatic fibrosis in Hep C. Friday, August 7, 2015. Posted by HCV New Drugs. Clinical Gastroenterology and Hepatology. Volume 13, Issue 8, Pages 1521–1531.e3. 2015 Aug;13(8):1521-1531.e3. doi: 10.1016/j.cgh.2015.01.030. Full Text Now Available, Click here. Coffee reduces the risk of hepatic fibrosis in Hep C. Coffee and caffeine are associated with decreased risk of advanced hepatic fibrosis among patients with Hepatitis C, reports the latest issue of the.
hepatitiscnewdrugs.blogspot.com
HCV New Drug Research : Hepatitis C - Janssen starts a study to evaluate simeprevir and odalasvir on AL-335 pharmacokinetics
https://hepatitiscnewdrugs.blogspot.com/2015/08/hepatitis-c-janssen-starts-study-to.html
HCV New Drug Research. Hepatitis C - Janssen starts a study to evaluate simeprevir and odalasvir on AL-335 pharmacokinetics. Monday, August 3, 2015. Posted by HCV New Drugs. Medivir announces that Janssen has started a phase I study to evaluate the effect of simeprevir and odalasvir on AL-335 pharmacokinetics. Approximately 150 million people are chronically infected with HCV globally*. When left untreated, HCV causes progressive liver disease in many of those who are chronically infected, and this c...
SOCIAL ENGAGEMENT